Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Urovant Sciences announced today that it has submitted a New Drug Application NDA to the US Food and Drug Administration FDA seeking approval of oncedaily mg vibegron for the treatment of patients with overactive bladder OAB with symptoms of urge uri...
Clover Biopharmaceuticals a global clinicalstage biotechnology company focused on developing novel and transformative biologic therapies today announced that the first patient was dosed in a Phase III trial of SCB a proposed biosimilar to Enbrel etan...
Under the patronage and presence of His Excellency the Minister of Transport Saleh Bin Nasser AlJasser OnMonday December Saudi Arabian Airlines Saudia launched the Saudi Arabian Logistics SAL Co the new independent entity within the Saudia Group whi...
AVITA Medical Limited a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration announced today that the US Food and Drug Administration FDA has approved the companys Investig...
Bridge Biotherapeutics Inc a clinical stage biotech company headquartered in Seongnam Republic of Korea announced that the Center for Drug Evaluation CDE of Chinas National Medical Products Administration NMPA cleared the Investigational New Drug IND...
Luye Pharma Group has announced submission of a new drug application NDA to the US Food and Drug Administration FDA for LY a new chemical drug for the treatment of major depressive disorder It is also the second US FDA NDA submission in the central n...
Gilead Sciences Inc and Eisai Co Ltd announced today that Gilead Sciences KK and Eisai have entered into an agreement for the distribution and copromotion of filgotinib an investigational oral selective JAK inhibitor in Japan pending regulatory appro...
FibroGen Inc today announced the submission of a New Drug Application NDA to the US Food and Drug Administration FDA for roxadustat for the treatment of anemia of chronic kidney disease CKD in both nondialysisdependent NDD and dialysisdependent DD CK...
Phathom Pharmaceuticals Inc a late clinicalstage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases announced today the initiation of PHALCONHP In this pivotal Phase clinical trial clin...
Polaryx Therapeutics Inc a biotech company developing patientfriendly small molecule therapeutics for lysosomal storage disorders such as Late Infantile Neuronal Ceroid Lipofuscinosis LINCL and other forms of NCL announced today that the Company has...
